0.00
price down icon100.00%   -5.00
 
loading
2 Seventy Bio Inc stock is traded at $0.00, with a volume of 0. It is down -100.00% in the last 24 hours and down -100.00% over the past month. 2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment focusing on researching, developing and commercializing potentially transformative treatments for cancer.
See More
Previous Close:
$5.00
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$266.14M
Revenue:
$44.12M
Net Income/Loss:
$-156.25M
P/E Ratio:
0.00
EPS:
-3.07
Net Cash Flow:
$-154.61M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
Value
$0.00
$0.00
1-Week Range:
Value
$0.00
$0.00
52-Week Range:
Value
$0.00
$5.30

2 Seventy Bio Inc Stock (TSVT) Company Profile

Name
Name
2 Seventy Bio Inc
Name
Phone
339-499-9300
Name
Address
60 BINNEY STREET, CAMBRIDGE
Name
Employee
65
Name
Twitter
Name
Next Earnings Date
2025-03-25
Name
Latest SEC Filings
Name
TSVT's Discussions on Twitter

Compare TSVT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
TSVT
2 Seventy Bio Inc
0.00 266.14M 44.12M -156.25M -154.61M -3.07
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
375.63 98.88B 11.42B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
559.80 58.84B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
435.10 56.12B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
672.35 41.20B 3.05B 1.28B -614.78M 19.58
Biotechnology icon
ONC
Beone Medicines Ltd Adr
298.29 35.49B 3.81B -644.79M -669.77M -6.24

2 Seventy Bio Inc Stock (TSVT) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-06-24 Downgrade Goldman Neutral → Sell
Jan-31-24 Upgrade Leerink Partners Market Perform → Outperform
Jan-31-24 Downgrade TD Cowen Outperform → Market Perform
Oct-30-23 Downgrade Leerink Partners Outperform → Market Perform
Oct-12-23 Initiated Citigroup Buy
Sep-13-23 Downgrade Goldman Buy → Neutral
Sep-12-23 Downgrade Guggenheim Buy → Neutral
Jul-28-23 Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-31-22 Initiated Guggenheim Buy
May-02-22 Initiated Goldman Buy
Feb-10-22 Initiated SVB Leerink Outperform
Jan-06-22 Initiated Cowen Outperform
Nov-09-21 Initiated Canaccord Genuity Buy
Nov-08-21 Initiated Morgan Stanley Overweight
Nov-08-21 Initiated Wedbush Outperform
View All

2 Seventy Bio Inc Stock (TSVT) Latest News

pulisher
Aug 07, 2025

How 2seventy bio Inc. stock performs during market volatilityControlled Entry Strategy With Safety Analytics - Newser

Aug 07, 2025
pulisher
Aug 07, 2025

Long term hold vs stop loss in 2seventy bio Inc.Free Safe Entry Stock Watch Suggestions - Newser

Aug 07, 2025
pulisher
Aug 06, 2025

Analyzing net buyer seller activity in 2seventy bio Inc.Swing Gain Strategy with Entry Forecast - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Momentum divergence signals in 2seventy bio Inc. chartFree Weekly Hot Picks With Buy Confidence - Newser

Aug 06, 2025
pulisher
Aug 04, 2025

Live Scanner Shows Breakout on 2seventy bio Inc.Watchlist for Smart Swing Trading Updated - metal.it

Aug 04, 2025
pulisher
Aug 03, 2025

What drives 2seventy bio Inc. stock priceAchieve rapid portfolio growth with expert guidance - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does 2seventy bio Inc. compare to its industry peersFree Stock Market Forecast Reports - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

2seventy bio Inc. Stock Analysis and ForecastConsistent double returns - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are the technical indicators suggesting about 2seventy bio Inc.Achieve rapid financial growth with expert help - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What are analysts’ price targets for 2seventy bio Inc. in the next 12 monthsDiscover breakthrough trading strategies - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How many analysts rate 2seventy bio Inc. as a “Buy”Explosive portfolio gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Should I hold or sell 2seventy bio Inc. stock in 2025Superior trading gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

How does 2seventy bio Inc. generate profit in a changing economyCapitalize on market momentum for maximum gains - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What is the dividend policy of 2seventy bio Inc. stockCapitalize on fast-growing investment opportunities - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

What makes 2seventy bio Inc. stock price move sharplyConsistently superior profits - Jammu Links News

Aug 03, 2025
pulisher
Aug 03, 2025

Is 2seventy bio Inc. stock overvalued or undervaluedHigh-profit stock alerts - Jammu Links News

Aug 03, 2025
pulisher
Aug 02, 2025

Why is 2seventy bio Inc. stock attracting strong analyst attentionUnbelievable profit margins - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

What are the latest earnings results for 2seventy bio Inc.Get expert insights on market-moving stocks - Jammu Links News

Aug 02, 2025
pulisher
Aug 02, 2025

When is 2seventy bio Inc. stock expected to show significant growthSpectacular growth rates - Jammu Links News

Aug 02, 2025
pulisher
Jul 29, 2025

Is 2seventy bio Inc. Stock a Good Fit for Conservative InvestorsBuy Alerts With Low Risk Confirmation Noted - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Is 2seventy bio Inc. forming a reversal patternTechnical Stock Breakout Predictions Signal Entry Points - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Momentum Screeners Rank 2seventy bio Inc. in Top 5 TodayAlpha Driven Watchlist With Alerts Published - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Heatmap Data Shows High Activity in 2seventy bio Inc. SectorReal Time Alerts Based on AI Prediction Triggered - metal.it

Jul 29, 2025
pulisher
Jul 29, 2025

Sector Leaders Rotate Capital Into 2seventy bio Inc.Breakout Confirmation With Entry Tracker Enabled - metal.it

Jul 29, 2025
pulisher
Jul 28, 2025

2seventy bio Inc. Company’s Quarterly Earnings Growth: What the Numbers SayAI Powered Stock Call - metal.it

Jul 28, 2025
pulisher
Jul 27, 2025

What catalysts could drive 2seventy bio Inc. stock higher in 2025Track emerging stocks with high growth potential - Jammu Links News

Jul 27, 2025
pulisher
Jul 27, 2025

How strong is 2seventy bio Inc. company’s balance sheetAchieve consistent double-digit growth - Jammu Links News

Jul 27, 2025
pulisher
Jul 27, 2025

Published on: 2025-07-27 15:37:28 - Jammu Links News

Jul 27, 2025
pulisher
Jul 25, 2025

Can 2seventy bio Inc. stock recover from recent declineExplosive earning power - Jammu Links News

Jul 25, 2025
pulisher
Jul 23, 2025

Why 2seventy bio Inc. stock attracts strong analyst attentionTop Performing Stocks - beatles.ru

Jul 23, 2025
pulisher
Jul 22, 2025

Is 2seventy bio Inc. a good long term investmentDynamic investment growth - Jammu Links News

Jul 22, 2025
pulisher
Jul 14, 2025

Krystal Biotech doses first patient in EMERALD-1 phase 1/2 trial for neurotrophic keratitis - Ophthalmology Times

Jul 14, 2025
pulisher
Jun 13, 2025

FDA Accepts NDA for Zoliflodacin, Potentially First Gonorrhea Antibiotic in Decades - Managed Healthcare Executive

Jun 13, 2025
pulisher
Jun 12, 2025

Cigna Launches AI Tools to Simplify Health Insurance, Improve Customer Experience - Managed Healthcare Executive

Jun 12, 2025
pulisher
Jun 12, 2025

FDA Approves Ibtrozi For Adults With ROS1+ NSCLC - Managed Healthcare Executive

Jun 12, 2025
pulisher
Jun 12, 2025

Alachua bio-manufacturing plant to lay off employees ahead of shutdown - WCJB | TV20

Jun 12, 2025
pulisher
Jun 12, 2025

'Life is too short to work on things that are mediocre': Why this biotech CEO's 2nd drug approval is a big deal - The Business Journals

Jun 12, 2025
pulisher
Jun 11, 2025

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC - Pharmacy Times

Jun 11, 2025
pulisher
Jun 09, 2025

Bonnie Hui-Callahan, Pharm.D., Video Interview | 2025 MHE Emerging Leaders in Healthcare - Managed Healthcare Executive

Jun 09, 2025
pulisher
Jun 08, 2025

Wellington Management Group LLP Reduces Stock Position in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Makes New Investment in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

Jun 05, 2025
pulisher
May 26, 2025

Deutsche Bank AG Has $1.10 Million Stock Position in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

May 26, 2025
pulisher
May 18, 2025

MHE Week in Review –Medicaid Bill Mayhem, UnitedHealth’s Stock Plummets and More - Managed Healthcare Executive

May 18, 2025
pulisher
May 15, 2025

Raymond James Financial Inc. Makes New $52,000 Investment in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

May 15, 2025
pulisher
May 15, 2025

2Seventy Bio Reports Strong Q1 2025 Earnings - TipRanks

May 15, 2025
pulisher
May 14, 2025

Investor relations - Bristol Myers Squibb

May 14, 2025
pulisher
May 13, 2025

Wells Fargo & Company MN Has $96,000 Stake in 2seventy bio, Inc. (NASDAQ:TSVT) - Defense World

May 13, 2025
pulisher
May 13, 2025

2seventy bio Completes Merger, Delists from Nasdaq - TipRanks

May 13, 2025
pulisher
May 07, 2025

Earnings call transcript: Nuvation Bio Q1 2025 sees strategic focus amid EPS miss - Investing.com India

May 07, 2025
pulisher
May 07, 2025

2seventy bio Reports First Quarter Financial Results and Provides Update on Proposed Acquisition by Bristol Myers Squibb - Business Wire

May 07, 2025
pulisher
May 06, 2025

Stelara Biosimilar Yesintek Gains Coverage on Leading Formularies - Managed Healthcare Executive

May 06, 2025

2 Seventy Bio Inc Stock (TSVT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$78.20
price up icon 0.71%
$37.01
price down icon 0.30%
$109.30
price down icon 1.76%
$28.07
price down icon 1.58%
$111.35
price up icon 0.04%
biotechnology ONC
$298.29
price down icon 0.08%
Cap:     |  Volume (24h):